Clinical Trial Update: Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating nuclear imaging techniques to subtype diagnose primary aldosteronism, with participant recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Snippet

Sponsor: University of Calgary | Conditions: Primary Aldosteronism | Phase 2 | Status: RECRUITING